Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity
Biomolecules · 2025
DOI: 10.3390/biom15060883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Wei Yen Chan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia. Hauptthemen laut MEDLINE: Polymerase Chain Reaction, Circulating Tumor DNA, Cell-Free Nucleic Acids. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CLEARbridge Foundation, Medical Research Future Fund, United States Department of Defense.
Abstract (Originalsprache)
Circulating tumour DNA (ctDNA) is a promising biomarker for personalised oncology. However, its clinical utility is limited by detection sensitivity, particularly in early-stage disease. T-Oligo Primed Polymerase Chain Reaction (TOP-PCR) is a commercial amplification approach utilising an efficient “half-adapter” ligation design and a single-primer-based PCR strategy. This study evaluated the clinical value and application of cell-free DNA (cfDNA) pre-amplification. cfDNA amplification with TOP-PCR preserved DNA size profiles and resulted in a 22 bp size increase due to the half-adaptor ligation. Gene target amplification rates varied, showing lower efficiency for the GC-rich TERT promoter amplicon and higher efficiency for the BRAF and TP53 amplicons. Optimised pre-amplification (20 ng cfDNA input and 5–7 cycles of PCR) enhanced ctDNA detection sensitivity and expanded sample availability for the detection of multiple tumour-informed mutations. Importantly, PCR errors emerged in pre-amplified cfDNA samples, underscoring the necessity for negative controls and the establishment of stringent mutation positivity thresholds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- Melanoma Institute of Australia, The University of Sydney, Sydney, NSW 2065, Australia.
- Centre for Precision Health, Edith Cowan University, Joondalup, WA 6027, Australia.
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
- Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW 2050, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2065, Australia.
ORCID-Profile: Wei Yen Chan, Ashleigh Stewart, Russell J Diefenbach, Elin S Gray, Jenny H Lee, Richard A Scolyer, Georgina V Long, Helen Rizos
Förderung
- CLEARbridge Foundation
- Medical Research Future Fund
- United States Department of Defense
- Melanoma Institute Australia
- Tour De Cure Postgraduate Research Grant
- National Health and Medical Research Council of Australia (NHMRC)
- University of Sydney Medical Foundation
Zitieren
APA
Chan, W. Y., Stewart, A., Diefenbach, R. J., Gray, E. S., Lee, J. H., Scolyer, R. A., Long, G. V., & Rizos, H. (2025). Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity. Biomolecules. https://doi.org/10.3390/biom15060883
Vancouver
Chan WY, Stewart A, Diefenbach RJ, Gray ES, Lee JH, Scolyer RA, et al. Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity. Biomolecules. 2025. doi:10.3390/biom15060883
BibTeX
@article{Chan2025,
author = {Chan, Wei Yen and Stewart, Ashleigh and Diefenbach, Russell J and Gray, Elin S and Lee, Jenny H and Scolyer, Richard A and Long, Georgina V and Rizos, Helen},
title = {Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15060883}
}
EUVIMED